Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 16/20 | 0.73 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ABL1 | P00519 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24118609 | 1.00 | IDO1 (0.73) | IDO1NPC1ALDH1A1GAARAB9A | |
| SCHEMBL21496434 | 1.00 | IDO1 (0.73) | IDO1NPC1ALDH1A1GAARAB9A | |
| SCHEMBL30056917 | 0.86 | IDO1 (0.69) | IDO1NPC1ALDH1A1GAARAB9A | |
| SCHEMBL21496402 | 0.85 | IDO1 (0.82) | IDO1SMN1; SMN2MEN1CYP1A2CYP2C9 | |
| SCHEMBL21496403 | 0.85 | IDO1 (0.82) | IDO1SMN1; SMN2MEN1CYP1A2CYP2C9 | |
| SCHEMBL30056914 | 0.85 | IDO1 (0.74) | IDO1NPC1RAB9ASMN1; SMN2MEN1 | |
| SCHEMBL21496391 | 0.85 | IDO1 (0.74) | IDO1NPC1RAB9ASMN1; SMN2MEN1 | |
| SCHEMBL21496390 | 0.85 | IDO1 (0.74) | IDO1NPC1RAB9ASMN1; SMN2MEN1 | |
| SCHEMBL21504302 | 0.85 | IDO1 (0.68) | IDO1MEN1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL21504017 | 0.85 | IDO1 (0.84) | IDO1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3781142-A1 | NOVEL [1.1.1] BICYCLO COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS | Merck Sharp&Dohme Corp. (US) | 2021-02-24 | — | — | EP | claimed |
| WO-2019204180-A1 | NOVEL [1.1.1] BICYCLO COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2019-10-24 | — | — | WO | claimed |